新型冠状病毒感染肺炎的实验诊断
陈福祥, 罗清琼, 徐北惠 . 新型冠状病毒感染肺炎的实验诊断[J]. 诊断学理论与实践, 2020 , 19(1) : 7 -10 . DOI: 10.16150/j.1671-2870.2020.01.003
| [1] | 国家卫生健康委员会办公厅, 国家中医药管理局办公室. 新型冠状病毒感染的肺炎诊疗方案(试行第六版)[R/OL]. [2020-02-24]http://www.nhc.gov.cn/xcs/zhengcwj/202002/8334a8326dd94d329df351d7da8aefc2.shtml |
| [2] | Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak[J]. Emerg Microbes Infect, 2020, 9(1):313-319. |
| [3] | Chu DKW, Pan Y, Cheng SMS, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia[J]. Clin Chem,pii:hvaa029. |
| [4] | Li T, Qiu Z, Zhang L, et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome[J]. J Infect Dis, 2004, 189(4):648-651. |
| [5] | Yilla M, Harcourt BH, Hickman CJ, et al. SARS-corona-virus replication in human peripheral monocytes/macrophages[J]. Virus Res, 2005, 107(1):93-101. |
| [6] | Zhang Z, Xu D, Li Y, et al. Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome[J]. Clin Immunol, 2005, 116(3):225-235. |
| [7] | Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med,2020,pii: S2213-2600(20)30076-X. |
| [8] | Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China[J/OL]. Allergy, 2020-02-19[2020-02-24]https://www.ncbi.nlm.nih.gov/pubmed/32077115. |
| [9] | 李太生, 邱志峰, 韩扬, 等. 严重急性呼吸综合征急性期T淋巴细胞亚群异常改变[J]. 中华检验医学杂志, 2003, 26(5):297-299. |
| [10] | 谢静, 范洪伟, 李太生, 等. 长期随访的严重急性呼吸综合征患者T淋巴细胞亚群动态变化[J]. 中国医学科学院报, 2006, 28(2):253-255. |
| [11] | Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, et al. Cytokine release syndrome[J]. J Immunother Cancer, 2018, 6(1):56. |
| [12] | Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza[J]. Crit Care, 2009, 13(6):R201. |
| [13] | Kindler E, Thiel V, Weber F. Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response[J]. Adv Virus Res, 2016, 96:219-243. |
| [14] | Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020, 395(10223):497-506. |
| [15] | Zhou YG, Fu BQ, Zheng XH, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus[J/OL]. BioRxiv preprint, 2020-02-20[2020-02-24]https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1. |
| [16] | Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona-virus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223):507-513. |
/
| 〈 |
|
〉 |
